Polymorphisms of hypoxia-related genes in subjects susceptible to acute mountain sickness

Respiration

Volumn 81, Issue 3, 2011, Pages 236-241

  Ding, Hui ^a   Liu, Qiuling ^a   Hua, Minglei ^a   Ding, Mengjiang ^a   Du, Haike ^a   Zhang, Weilong ^b   Li, Zengde ^b   Zhang, Jianpeng ^a  

^a GENERAL HOSPITAL OF CHINESE PEOPLE'S ARMED POLICE FORCES   (China)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Acute mountain sickness; Hypoxia; Single nucleotide polymorphisms

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; HEAT SHOCK PROTEIN 70; HYPOXIA INDUCIBLE FACTOR 1; VASCULOTROPIN A;

ADULT; AGE; ALTITUDE; ALTITUDE DISEASE; ARTICLE; CHINESE; CONTROLLED STUDY; GENE FREQUENCY; GENETIC ASSOCIATION; GENOTYPE; HAPLOTYPE; HEART RATE; HUMAN; MALE; OXYGEN SATURATION; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

ADOLESCENT; ALTITUDE SICKNESS; ANOXIA; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; CHINA; GENETIC PREDISPOSITION TO DISEASE; HSP70 HEAT-SHOCK PROTEINS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1; MALE; MILITARY PERSONNEL; NITRIC OXIDE SYNTHASE TYPE III; POLYMORPHISM, SINGLE NUCLEOTIDE; VASCULAR ENDOTHELIAL GROWTH FACTOR A; YOUNG ADULT;

EID: 79952281081     PISSN: 00257931     EISSN: None     Source Type: Journal    
DOI: 10.1159/000322850     Document Type: Article

References (32)

1. Roach RC, Bärtsch P, Oelz O, Hackett PH: The Lake Louise acute mountain sickness scoring system; in Sutton JR, Houston CS, Coates G (eds): Hypoxia and Molecular Medicine. Burlington, Queen City Printers, 1993.
2. Basnyat B, Murdoch DR: High-altitude illness. Lancet 2003;361:1967-1974. (Pubitemid 36694589)
3. Bartsch P, Bailey DM, Berger MM, Knauth M, Baumgartner RW: Acute mountain sickness: controversies and advances. High Alt Med Biol 2004;5:110-124. (Pubitemid 39069613)
4. Maggiorini M, Buhler B, Walter M, Oelz O: Prevalence of acute mountain sickness in the Swiss Alps. BMJ 1990;301:853-855. (Pubitemid 20342788)
5. Barry PW, Pollard AJ: Altitude illness. BMJ 2003;326:915-919. (Pubitemid 36528952)
6. Basnyat B, Cumbo TA, Edelman R: Infections at high altitude. Clin Infect Dis 2001;33:1887-1891. (Pubitemid 33105130)
7. Dumont L, Mardirosoff C, Tramer MR: Efficacy and harm of pharmacological prevention of acute mountain sickness: quantitative systematic review. BMJ 2000;321:267-272. (Pubitemid 30487464)
8. Zhou F, Wang F, Li F, Yuan J, Zeng H, Wei Q, Tanguay RM, Wu T: Association of hsp70-2 and hsp-hom gene polymorphisms with risk of acute high-altitude illness in a Chinese population. Cell Stress Chaperones 2005;10:349-356. (Pubitemid 41813382)
9. Hackett PH, Roach RC: High-altitude illness. N Engl J Med 2001;345:107-114. (Pubitemid 32634570)
10. Krenn K, Klepetko W, Taghavi S, Paulus P, Aharinejad S: Vascular endothelial growth factor increases pulmonary vascular permeability in cystic fibrosis patients undergoing lung transplantation. Eur J Cardiothorac Surg 2007;32:35-41. (Pubitemid 46874980)
11. Yoon D, Pastore YD, Divoky V, Liu E, Mlodnicka AE, Rainey K, Ponka P, Semenza GL, Schumacher A, Prchal JT: Hypoxia-inducible factor-1 deficiency results in dysregulated erythropoiesis signaling and iron homeostasis in mouse development. J Biol Chem 2006;281:25703-25711. (Pubitemid 44401959)
12. Wang X, Xu C, Wang D, Wang Q, Zhang B: Heat shock response and mammal adaptation to high elevation (hypoxia). Sci China C Life Sci 2006;49:500-512. (Pubitemid 44562899)
13. Kojda G, Hambrecht R: Molecular mechanisms of vascular adaptations to exercise. Physical activity as an effective antioxidant therapy? Cardiovasc Res 2005;67:187-197. (Pubitemid 40943611)
14. Coulet F, Nadaud S, Agrapart M, Soubrier F: Identification of hypoxia-response element in the human endothelial nitric-oxide synthase gene promoter. J Biol Chem 2003;278:46230-46240. (Pubitemid 37452193)
15. Maloney JP, Broeckel U: Epidemiology, risk factors, and genetics of high-altitude-related pulmonary disease. Clin Chest Med 2005;26:395-404, v. (Pubitemid 41755348)
16. Maloney J, Wang D, Duncan T, Voelkel N, Ruoss S: Plasma vascular endothelial growth factor in acute mountain sickness. Chest 2000;118:47-52. (Pubitemid 30485488)
17. Hackett PH, Oelz O: The Lake Louise consensus on the definition and quantification of altitude illness; in Sutton JR, Coates G, Houston CS (eds): Hypoxia and Mountain Medicine. Burlington, Queen City Printers, 1992.
18. Rupert JL, Koehle MS: Evidence for a genetic basis for altitude-related illness. High Alt Med Biol 2006;7:150-167. (Pubitemid 44043593)
19. Wang P, Ha AY, Kidd KK, Koehle MS, Rupert JL: A variant of the endothelial nitric oxide synthase gene (NOS3) associated with AMS susceptibility is less common in the Quechua, a high altitude Native population. High Alt Med Biol 2010;11:27-30.
20. Hackett PH, Rennie D: Rales, peripheral edema, retinal hemorrhage and acute mountain sickness. Am J Med 1979;67:214-218. (Pubitemid 9239514)
21. Appenzeller O, Minko T, Qualls C, Pozharov V, Gamboa J, Gamboa A, Wang Y: Gene expression, autonomic function and chronic hypoxia: lessons from the Andes. Clin Auton Res 2006;16:217-222. (Pubitemid 43885548)
22. Gabriel S, Ziaugra L, Tabbaa D: SNP genotyping using the Sequenom MassARRAY iPLEX platform. Curr Protoc Hum Genet 2009; chapter 2:unit 2.12.
23. Christou H, Yoshida A, Arthur V, Morita T, Kourembanas S: Increased vascular endothelial growth factor production in the lungs of rats with hypoxia-induced pulmonary hypertension. Am J Respir Cell Mol Biol 1998;18:768-776. (Pubitemid 128358423)
24. Levy AP, Levy NS, Wegner S, Goldberg MA: Transcriptional regulation of the rat vascular endothelial growth factor gene by hypoxia. J Biol Chem 1995;270:13333-13340.
25. Fehrenbach H, Kasper M, Haase M, Schuh D, Muller M: Differential immunolocalization of VEGF in rat and human adult lung, and in experimental rat lung fibrosis: light, fluorescence, and electron microscopy. Anat Rec 1999;254:61-73. (Pubitemid 29024781)
26. Pham I, Uchida T, Planes C, Ware LB, Kaner R, Matthay MA, Clerici C: Hypoxia upregulates VEGF expression in alveolar epithelial cells in vitro and in vivo. Am J Physiol Lung Cell Mol Physiol 2002;283: L1133-L1142. (Pubitemid 35204907)
27. Pages G, Pouyssegur J: Transcriptional regulation of the vascular endothelial growth factor gene - a concert of activating factors. Cardiovasc Res 2005;65:564-573. (Pubitemid 40138977)
28. Tahara T, Shibata T, Nakamura M, Yamashita H, Yoshioka D, Hirata I, Arisawa T: Effect of polymorphisms in the 3′ untranslated region (3′-UTR) of vascular endothelial growth factor gene on gastric cancer and peptic ulcer diseases in Japan. Mol Carcinog 2009;48:1030-1037.
29. Masago K, Fujita S, Kim YH, Hatachi Y, Fukuhara A, Nagai H, Irisa K, Ichikawa M, Mio T, Mishima M: Effect of vascular endothelial growth factor polymorphisms on survival in advanced-stage non-small-cell lung cancer. Cancer Sci 2009;100:1917-1922.
30. Tissot van Patot MC, Leadbetter G, Keyes LE, Bendrick-Peart J, Beckey VE, Christians U, Hackett P: Greater free plasma VEGF and lower soluble VEGF receptor-1 in acute mountain sickness. J Appl Physiol 2005;98:1626-1629. (Pubitemid 40570769)
31. Hanaoka M, Droma Y, Naramoto A, Honda T, Kobayashi T, Kubo K: Vascular endothelial growth factor in patients with high-altitude pulmonary edema. J Appl Physiol 2003;94:1836-1840. (Pubitemid 36457433)
32. Dorward DA, Thompson AA, Baillie JK, MacDougall M, Hirani N: Change in plasma vascular endothelial growth factor during onset and recovery from acute mountain sickness. Respir Med 2007;101:587-594. (Pubitemid 46209926)